Models for event-driven data: longitudinal daily adverse event and dropout.
Miller
Raymond
R
Global Pharmacometrics, Pfizer, Inc, New London, Connecticut, USA. ramiller@dsi.com
Ito
Kaori
K
Lalovic
Bojan
B
D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects; D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D003198:Computer Simulation; D004305:Dose-Response Relationship, Drug; D015195:Drug Design; D006801:Humans; D008137:Longitudinal Studies; D015233:Models, Statistical; D010352:Patient Dropouts; D000069583:Pregabalin; D012720:Severity of Illness Index; D013997:Time Factors; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives
D014151:Anti-Anxiety Agents; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid